Growth and tolerance studies of a new infant formula

Clinical Pediatrics
|November 1, 1984
PubMed

Insights

A new infant formula was clinically tested in 337 newborns. The formula demonstrated favorable comparisons in growth, tolerance, and biochemical markers against control formulas and breast milk.

Area of Science:

  • Pediatrics
  • Nutritional Science
  • Infant Health

Background:

  • Development of novel infant nutrition is crucial for supporting healthy growth.
  • Existing formulas require ongoing comparison with breast milk and control formulations.
  • Clinical validation is essential for new infant feeding products.

Purpose of the Study:

  • To evaluate the clinical performance of a new routine infant formula.
  • To compare the new formula against standard control formulas and breast-fed infants.
  • To assess key growth, tolerance, and biochemical parameters in healthy newborns.

Main Methods:

  • A clinical study involving 337 normal newborns across six pediatric practices.
  • Regular infant examinations up to six months of age.
  • Comparative analysis of serum biochemistries, hematology, growth, and tolerance variables.

Main Results:

  • The new infant formula formulation compared favorably across all studied variables.
  • No adverse effects or significant deviations were noted in growth or tolerance.
  • Biochemical and hematological markers were consistent with healthy infant development.

Conclusions:

  • The new routine infant formula is safe and effective for term newborns.
  • This formulation supports normal infant growth and development comparable to breast milk.
  • Clinical data supports the use of this new formula in routine infant feeding.